CJC-1295 & Ipamorelin

This research bundle pairs CJC-1295 with Ipamorelin, creating a powerful synergistic duo for studying growth hormone (GH) axis optimization. CJC-1295 acts as a growth hormone-releasing hormone (GHRH) analog, while Ipamorelin functions as a selective ghrelin receptor agonist. Together, they are widely studied for their ability to stimulate a robust, natural, and pulsatile release of endogenous growth hormone, supporting tissue repair, recovery, and metabolic function. Both compounds are lab-tested for high-purity standards